Inactive Instrument

Highlights Galaxy Biomedical Investment Co., Ltd.

Equities

000806

CNE0000009R7

Highlights

Unlock all the news: Be the first to know and act before the market!

Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-30	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-29	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-29	CI
Galaxy Biomedical Investment : Shenzhen Bourse Drops Delisting Risk Alert on Galaxy Biomedical; Shares Rise 5%	21-06-22	MT
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-14	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-30	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-27	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-04-29	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-14	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019	19-10-30	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-30	CI
Galaxy Biomedical Investment Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-04-26	CI
Galaxy Biomedical Investment Co., Ltd. cancelled the acquisition of 5.6% stake in Yunnan Hansu Biological Technology Co., Ltd. from Hanma Investment Group Co., Ltd.	19-04-25	CI
Guangxi Yinhe Group Co., Ltd. cancelled the acquisition of 60% stake in Jiangsu Decon Bio-Sci-Technology Co., Ltd. from Galaxy Biomedical Investment Co., Ltd..	18-08-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Galaxy Biomedical Investment Co., Ltd.

Equities

000806

CNE0000009R7

Highlights

Filters